Download PDF
Semin Respir Crit Care Med 2001; 22(1): 061-074
DOI: 10.1055/s-2001-13841
Copyright © 2001 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Inotrope/Vasopressor Support in Sepsis-Induced Organ Hypoperfusion

Jean-Louis Vincent, Daniel De Backer
  • Department of Intensive Care, Erasme University Hospital, Free University of Brussels, Belgium
Further Information

Publication History

Publication Date:
31 December 2001 (online)

    Permissions and Reprints

ABSTRACT

Vasoactive agents are commonly required in the management of septic shock not only to restore a sufficient tissue perfusion pressure but also to increase blood flow and oxygen delivery to the organs. Importantly, vasoactive agents are no substitute for fluid therapy. Defining end points for therapy remains difficult. These should be, above all, clinical. Even though the gut may play an important role in the development of multiple organ failure, the use of gastric tonometry to guide therapy cannot be recommended at this time. Study of the microcirculation at the bedside with orthogonal polarization spectral imaging may be helpful in the future. Adrenergic agents are the preferred agents for hemodynamic stabilization. Dopamine and norepinephrine are the drugs of choice to increase arterial pressure. Dobutamine remains the agent of choice to increase blood flow to the organs, including the gut and the kidneys. Many questions remain unanswered with respect to optimal hemodynamic management of septic shock.

KEYWORD

Splanchnic circulation - gastric tonometry - adrenergic agents - circulatory shock - multiple organ failure

REFERENCES

  • 1 Pinsky M R, Matuschak G M. Cardiovascular determinants of the hemodynamic response to acute endotoxemia in the dog.  J Crit Care . 1986;  1 18-31
    PubMedGoogle Scholar
  • 2 Abel F L, Beck R R. Canine peripheral vascular response to endotoxin shock at a constant cardiac output.  Circ Shock . 1988;  25 267-74
    PubMedGoogle Scholar
  • 3 Brienza N, Ayuse T, Revelly J P. Effects of endotoxin on isolated porcine liver: pressure-flow analysis.  J Appl Physiol . 1995;  78 784-792
    PubMedGoogle Scholar
  • 4 Lorente J A, Landin L, De Pablo R. L-arginine pathway in the sepsis syndrome.  Crit Care Med . 1993;  21 1287-1295
    PubMedGoogle Scholar
  • 5 Krafte-Jacobs B, Brilli R, Szabó C. Circulating methemoglobin, nitrate and nitrite concentrations as indicators of nitric oxide overproduction in critically ill children with septic shock.  Crit Care Med . 1997;  25 1588-1593
    CrossrefPubMedGoogle Scholar
  • 6 Parrillo J E, Burch C, Shelhamer J H. A circulating myocardial depressant substance in humans with septic shock.  J Clin Invest . 1985;  76 1539-1553
    PubMedGoogle Scholar
  • 7 Parker M M, Suffredini A F, Natanson C. Responses of left ventricular function in survivors and nonsurvivors of septic shock.  J Crit Care . 1989;  4 19-25
    CrossrefPubMedGoogle Scholar
  • 8 Suffredini A F, Fromm R E, Parker M M. The cardiovascular response of normal humans to the administration of endotoxin.  N Engl J Med . 1989;  321 280-287
    CrossrefPubMedGoogle Scholar
  • 9 Vincent J L, Gris P, Coffernils M. Myocardial depression characterizes the fatal course of septic shock.  Surgery . 1992;  111 660-667
    PubMedGoogle Scholar
  • 10 Sibbald W J. Myocardial oxygen metabolism in the sepsis syndrome. In: Gutierrez G, ed. Tissue Oxygen Utilization Berlin: Springer-Verlag 1991: 185-199
    Google Scholar
  • 11 Spies C, Haude V, Fitzner R. Serum cardiac troponin T as a prognostic marker in early sepsis.  Chest . 1998;  113 1055-1063
    PubMedGoogle Scholar
  • 12 Dhainaut J F, Huyghebaert M F, Monsallier J F. Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock.  Circulation . 1987;  75 533-541
    CrossrefPubMedGoogle Scholar
  • 13 Parker M M, Shelhamer J H, Natanson C. Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis.  Crit Care Med . 1987;  15 923-929
    CrossrefPubMedGoogle Scholar
  • 14 Vincent J L, Creteur J. Gastric mucosal pH (pHi) is definitely obsolete: please tell us more about gastric mucosal PCO2 (PgCO2).  Crit Care Med . 1998;  26 1479-1481
    PubMedGoogle Scholar
  • 15 Doglio G R, Pusajo J F, Egurrola M A. Gastric mucosal pH as a prognostic index of mortality in critically ill patients.  Crit Care Med . 1991;  19 1037-1040
    PubMedGoogle Scholar
  • 16 Friedman G, Berlot G, Kahn R J, Vincent J L. Combined measurements of blood lactate concentrations and gastric intramucosal pH in patients with severe sepsis.  Crit Care Med . 1995;  23 1184-1193
    PubMedGoogle Scholar
  • 17 Ivatury R R, Simon R J, Havriliak D. Gastric mucosal pH and oxygen delivery and oxygen consumption indices in the assessment of adequacy of resuscitation after trauma: a prospective, randomized study.  J Trauma . 1995;  39 128-134
    PubMedGoogle Scholar
  • 18 Gutierrez G, Palizas F, Doglio G. Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients.  Lancet . 1992;  339 195-199
    PubMedGoogle Scholar
  • 19 Gomersall C D, Joynt G M, Freebairn R C. Resuscitation of critically ill patients based on the results of gastric tonometry: a prospective, randomized, controlled trial.  Crit Care Med . 2000;  28 607-614
    PubMedGoogle Scholar
  • 20 Creteur J, De Backer D, Vincent J L. Does gastric tonometry monitor splanchnic perfusion?.  Crit Care Med . 1999;  27 2480-2484
    PubMedGoogle Scholar
  • 21 Ellis C. Microcirculatory flows, microcirculatory responsiveness, microcirculatory and regional (arteriolar/venular O2 saturations. In: Sibbald WJ, Messmer K, Fink MP, eds. Tissue Oxygenation in Acute Medicine Heidelberg: Springer 1998: 204-225
    Google Scholar
  • 22 De Backer D, Creteur J, Vincent J L. Evidence for alteration of microvascular blood flow in patients with shock states.  Am J Respir Crit Care Med . 2000;  161 A884(Abstract)
    PubMedGoogle Scholar
  • 23 Carrico C J, Meakins J L, Marshall J C. Multiple organ failure syndrome.  Arch Surg . 1986;  121 196-208
    CrossrefPubMedGoogle Scholar
  • 24 Marshall J C, Christou N V, Meakins J L. The gastrointestinal tract: the ``undrained abscess'' of multiple organ failure.  Ann Surg . 1993;  218 111-119
    CrossrefPubMedGoogle Scholar
  • 25 Landow L, Andersen L W. Splanchnic ischaemia and its role in multiple organ failure.  Acta Anaesthesiol Scand . 1994;  38 626-639
    PubMedGoogle Scholar
  • 26 Mythen M G, Webb A R. The role of gut mucosal hypoperfusion in the pathogenesis of post-operative organ dysfunction.  Intensive Care Med . 1994;  20 203-209
    CrossrefPubMedGoogle Scholar
  • 27 Ohri S K, Somasundaram S, Koak Y. The effect of intestinal hypoperfusion on intestinal absorption and permeability during cardiopulmonary bypass.  Gastroenterology . 1994;  106 318-323
    PubMedGoogle Scholar
  • 28 Meier-Hellmann A, Specht M, Hannemann L. Splanchnic blood flow is greater in septic shock treated with norepinephrine than in severe sepsis.  Intensive Care Med . 1996;  22 1354-1359
    PubMedGoogle Scholar
  • 29 Vallet B, Lund N, Curtis S E. Gut and muscle tissue PO2 in endotoxemic dogs during shock and resuscitation.  J Appl Physiol . 1994;  76 793-800
    PubMedGoogle Scholar
  • 30 Dahn M S, Lange M P, Wilson R F. Hepatic blood flow and splanchnic oxygen consumption measurements in clinical sepsis.  Surgery . 1990;  107 295-301
    PubMedGoogle Scholar
  • 31 Steffes C P, Dahn M S, Lange M P. Oxygen transport-dependent splanchnic metabolism in the sepsis syndrome.  Arch Surg . 1994;  129 46-52
    PubMedGoogle Scholar
  • 32 Reinelt H, Radermacher P, Fischer G. Effects of a dobutamine-induced increase in splanchnic blood flow on hepatic metabolic activity in patients with septic shock.  Anesthesiology . 1997;  86 818-824
    CrossrefPubMedGoogle Scholar
  • 33 Schmidt H, Secchi A, Wellmann R. Effect of endotoxemia on intestinal villus microcirculation in rats.  J Surg Res . 1996;  61 521-526
    CrossrefPubMedGoogle Scholar
  • 34 Lam C, Tyml K, Martin C, Sibbald W. Microvascular perfusion is impaired in a rat model of normotensive sepsis.  J Clin Invest . 1994;  94 2077-2083
    CrossrefPubMedGoogle Scholar
  • 35 Piper R D, Pitt-Hyde M L, Anderson L A. Leukocyte activation and flow behavior in rat skeletal muscle in sepsis.  Am J Respir Crit Care Med . 1998;  157 129-134
    PubMedGoogle Scholar
  • 36 Farquhar I, Martin C M, Lam C. Decreased capillary density in vivo in bowel mucosa of rats with normotensive sepsis.  J Surg Res . 1996;  61 190-196
    CrossrefPubMedGoogle Scholar
  • 37 Walley K R. Heterogeneity of oxygen delivery impairs oxygen extraction by peripheral tissues: theory.  J Appl Physiol . 1996;  81 885-894
    PubMedGoogle Scholar
  • 38 Humer M F, Phang P T, Friesen B P. Heterogeneity of gut capillary transit times and impaired gut oxygen extraction in endotoxemic pigs.  J Appl Physiol . 1996;  81 895-904
    PubMedGoogle Scholar
  • 39 Rudis M I, Basha M A, Zarowitz B J. Is it time to reposition vasopressors and inotropes in sepsis?.  Crit Care Med . 1996;  24 525-537
    PubMedGoogle Scholar
  • 40 Silva E, De Backer D, Creteur J, Vincent J L. Effects of vasoactive drugs on gastric intramucosal pH.  Crit Care Med . 1998;  26 1749-1758
    PubMedGoogle Scholar
  • 41 Kreimeier U, Brueckner U B, Gerspach S. A porcine model of hyperdynamic endotoxemia: pattern of respiratory, macrocirculatory, and regional blood flow changes.  J Invest Surg . 1993;  6 143-156
    PubMedGoogle Scholar
  • 42 Bland R D, Shoemaker W C, Abraham E, Cobo J C. Hemodynamic and oxygen transport patterns in surviving and nonsurviving postoperative patients.  Crit Care Med . 1985;  13 85-90
    PubMedGoogle Scholar
  • 43 Bishop M, Shoemaker W C, Appel P. Relationship between supranormal circulatory values, time delays and outcome in severely traumatized patients.  Crit Care Med . 1993;  21 56-63
    CrossrefPubMedGoogle Scholar
  • 44 Hayes M A, Timmins A C, Yau E H. Elevation of systemic oxygen delivery in the treatment of critically ill patients.  N Engl J Med . 1994;  330 1717-1722
    CrossrefPubMedGoogle Scholar
  • 45 Gattinoni L, Brazzi L, Pelosi P. A trial of goal-oriented hemodynamic therapy in critically ill patients.  N Engl J Med . 1995;  333 1025-1032
    CrossrefPubMedGoogle Scholar
  • 46 Kvietys P R, Granger D N. Vasoactive agents and splanchnic oxygen uptake.  Am J Physiol . 1982;  243 G1-G9
    PubMedGoogle Scholar
  • 47 Braatveld G D, Flynn M D, Stanners A. Splanchnic blood flow in man: evidence for mediation via a β-adrenergic mechanism.  Clin Sci (Colch ) . 1993;  84 201-207
    PubMedGoogle Scholar
  • 48 Russell J A. Catecholamines and the splanchnic circulation.  Crit Care Med . 1999;  27 242-243
    PubMedGoogle Scholar
  • 49 Uusaro A, Russell J A. Could anti-inflammatory actions of catecholamines explain the possible beneficial effects of supranormal oxygen delivery in critically ill surgical patients?.  Intensive Care Med . 2000;  26 299-304
    CrossrefPubMedGoogle Scholar
  • 50 Ruokonen E, Takala J, Kari A. Regional blood flow and oxygen transport in septic shock.  Crit Care Med . 1993;  21 1296-303
    PubMedGoogle Scholar
  • 51 Meier-Hellmann A, Bredle D L, Specht M. The effects of low dose dopamine on splanchnic blood flow and oxygen uptake in patients with septic shock.  Intensive Care Med . 1997;  23 31-37
    CrossrefPubMedGoogle Scholar
  • 52 Maynard N D, Bihari D J, Dalton R N. Increasing splanchnic blood flow in the critically ill.  Chest . 1995;  108 1648-1654
    PubMedGoogle Scholar
  • 53 Nevière R, Mathieu D, Chagnon J L. The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in septic patients.  Am J Respir Crit Care Med . 1996;  154 1684-1688
    PubMedGoogle Scholar
  • 54 Gardeback M, Settergren G. Dopexamine and dopamine in the prevention of low gastric mucosal pH following cardiopulmonary bypass.  Acta Anaesthesiol Scand . 1995;  39 1066-1070
    PubMedGoogle Scholar
  • 55 Olson D, Pohlman A, Hall J B. Administration of low dose dopamine to nonoliguric patients with sepsis syndrome does not raise gastric intramucosal pH nor improve creatinine clearance.  Am J Respir Crit Care Med . 1996;  154 1664-1670
    PubMedGoogle Scholar
  • 56 Marik P E, Mohedin J. The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis.  JAMA . 1994;  272 1354-1357
    CrossrefPubMedGoogle Scholar
  • 57 Soong C V, Halliday M I, Hood J M. Effect of low dose dopamine on sigmoid colonic intramucosal pH in patients undergoing elective abdominal aortic aneurysm repair.  Br J Surg . 1995;  82 912-915
    PubMedGoogle Scholar
  • 58 Smithies M, Yee T H, Jacson L. Protecting the gut and the liver in the critically ill: effects of dopexamine.  Crit Care Med . 1994;  22 789-795
    PubMedGoogle Scholar
  • 59 Levy B, Nace L, Bollaert P E. Comparison of systemic and regional effects of dobutamine and dopexamine in norepinephrine-treated septic shock.  Intensive Care Med . 1999;  25 942-948
    CrossrefPubMedGoogle Scholar
  • 60 Temmesfeld-Wollbruck B, Szalay A, Mayer K. Abnormalities of gastric mucosal oxygenation in septic shock: partial responsiveness to dopexamine.  Am J Respir Crit Care Med . 1998;  157 1586-1592
    PubMedGoogle Scholar
  • 61 Meier-Hellmann A, Bredle D L, Specht M. Dopexamine increases splanchnic blood flow but decreases gastric mucosal pH in severe septic patients treated with dobutamine.  Crit Care Med . 1999;  27 2166-2171
    PubMedGoogle Scholar
  • 62 Kiefer P, Tugtekin I, Wiedeck H. Effect of a dopexamine-induced increase in cardiac index on splanchnic hemodynamics in septic shock.  Am J Respir Crit Care Med . 2000;  161 775-779
    PubMedGoogle Scholar
  • 63 Meier-Hellmann A, Reinhart K. Influence of catecholamines on regional perfusion and tissue oxygenation in septic shock patients. In: Reinhart K, Eyrich K, Sprung C, eds. Sepsis: Current Perspectives in Pathophysiology and Therapy Berlin, Heidelberg, New York: Springer-Verlag 1994: 274-291
    Google Scholar
  • 64 Reinelt H, Radermacher P, Kiefer P. Impact of exogenous β-adrenoreceptor stimulation on hepato-splanchnic oxygen kinetics and metabolic activity in septic shock.  Crit Care Med . 1999;  27 325-331
    PubMedGoogle Scholar
  • 65 Meier-Hellmann A, Hannemann L, Specht M. The relationship between mixed venous and hepatic venous O2 saturation in patients with septic shock. In: Vaupel P, ed. Oxygen transport to the tissues XV New York: Plenum 1994: 701-707
    Google Scholar
  • 66 Meier-Hellmann A, Reinhart K, Bredle D L. Epinephrine impairs splanchnic perfusion in septic shock.  Crit Care Med . 1997;  25 399-404
    PubMedGoogle Scholar
  • 67 Levy B, Bollaert P E, Charpentier C. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock.  Intensive Care Med . 1997;  23 282-287
    CrossrefPubMedGoogle Scholar
  • 68 Duranteau J, Sitbon P, Teboul J L. Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock.  Crit Care Med . 1999;  27 893-900
    CrossrefPubMedGoogle Scholar
  • 69 De Backer D, Creteur J, Noordally O. Does hepatosplanchnic VO2/DO2 dependency exist in critically ill patients?.  Am J Respir Crit Care Med . 1998;  157 1219-1225
    PubMedGoogle Scholar
  • 70 Gutierrez G, Clark C, Brown S D. Effect of dobutamine on oxygen consumption and gastric mucosal pH in septic patients.  Am J Respir Crit Care Med . 1994;  150 324-329
    PubMedGoogle Scholar
  • 71 Silverman H, Tuma P. Gastric tonometry in patients with sepsis: effects of dobutamine infusions and packed red blood cell transfusions.  Chest . 1992;  102 184-188
    PubMedGoogle Scholar
  • 72 Esen F, Telci L, Çakar N. Evaluation of gastric intramucosal pH measurements with tissue oxygenation indices in patients with severe sepsis.  Clin Intensive Care . 1996;  7 180-189
    PubMedGoogle Scholar
  • 73 Levy B, Bollaert P E, Lucchelli J P. Dobutamine improves the adequacy of gastric mucosal perfusion in epinephrine-treated septic shock.  Crit Care Med . 1997;  25 1649-1654
    PubMedGoogle Scholar
  • 74 Joly L M, Monchi M, Cariou A. Effects of dobutamine on gastric mucosal perfusion and hepatic metabolism in patients with septic shock.  Am J Respir Crit Care Med . 1999;  160 1983-1986
    PubMedGoogle Scholar
  • 75 Szerlip H M. Renal-dose dopamine: fact and fiction.  Ann Intern Med . 1991;  115 153-154
    PubMedGoogle Scholar
  • 76 Vincent J L. Renal effects of dopamine: may our dream ever come true ?.  <~>(Editorial). Crit Care Med . 1994;  22 5-6
    PubMedGoogle Scholar
  • 77 Thompson B T, Cockrill B A. Renal-dose dopamine: a siren song?.  Lancet . 1994;  344 7-8
    CrossrefPubMedGoogle Scholar
  • 78 McCrory C, Cunningham A J. Low dose dopamine: will there ever be a scientific rationale?.  Br J Anaesth . 1997;  78 350-351
    PubMedGoogle Scholar
  • 79 McDonald R H, Goldberg L I, McNay J L, Tuttle E P. Effects of dopamine in man: augmentation of sodium excretion, glomerular filtration rate and renal plasma flow.  J Clin Invest . 1964;  43 1116-1124
    CrossrefPubMedGoogle Scholar
  • 80 Swygert T H, Roberts L C, Valek T R. Effect of intraoperative low dose dopamine on renal function in liver transplant recipients.  Anesthesiology . 1991;  75 571-576
    PubMedGoogle Scholar
  • 81 Kadieva V S, Friedman L, Margolius L P. The effect of dopamine on graft function in patients undergoing renal transplantation.  Anesth Analg . 1993;  76 362-365
    PubMedGoogle Scholar
  • 82 Baldwin L, Henderson A, Hickman P. Effect of postoperative low dose dopamine on renal function after elective major vascular surgery.  Ann Intern Med . 1994;  120 744-747
    PubMedGoogle Scholar
  • 83 Chertow G M, Sayegh M H, Allgren R L. Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure?.  Am J Med . 1996;  101 49-53
    CrossrefPubMedGoogle Scholar
  • 84 Lherm T, Troché G, Rossignol M. Renal effects of low dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines.  Intensive Care Med . 1996;  22 213-219
    CrossrefPubMedGoogle Scholar
  • 85 Day N P, Phu N H, Mai N T. Effects of dopamine and epinephrine infusions on renal hemodynamics in severe malaria and severe sepsis.  Crit Care Med . 2000;  28 1353-1362
    PubMedGoogle Scholar
  • 86 Van den Berghe G, de Zegher F. Anterior pituitary function during critical illness and dopamine treatment.  Crit Care Med . 1996;  24 1580-1590
    CrossrefPubMedGoogle Scholar
  • 87 Van de Borne P, Oren R, Somers V K. Dopamine depresses minute ventilation in patients with heart failure.  Circulation . 1998;  98 126-131
    PubMedGoogle Scholar
  • 88 Bellomo R, Kellum J A, Wisniewski S R, Pinsky M R. Effects of norepinephrine on the renal vasculature in normal and endotoxemic dogs.  Am J Respir Crit Care Med . 1999;  159 1186-1192
    PubMedGoogle Scholar
  • 89 Desjars P, Pinaud M, Potel G. A reappraisal of norepinephrine therapy in human septic shock.  Crit Care Med . 1987;  15 134-137
    PubMedGoogle Scholar
  • 90 Martin C, Papazian L, Perrin G. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock?.  Chest . 1993;  103 1826-1831
    CrossrefPubMedGoogle Scholar
  • 91 Redl-Wenzl E M, Armbruster C, Edelmann G. The effects of norepinephrine on hemodynamics and renal function in severe septic shock states.  Intensive Care Med . 1993;  19 151-154
    CrossrefPubMedGoogle Scholar
  • 92 Schwieger I M, Schiffer E R, Morel D R. Effects of fenoldopam on systemic and splanchnic hemodynamics and oxygen delivery/consumption relationship during hyperdynamic ovine endotoxaemia.  Intensive Care Med . 1998;  24 509-518
    CrossrefPubMedGoogle Scholar
  • 93 Schmidt H, Secchi A, Wellmann R. Effect of low dose dopamine on intestinal villus microcirculation during normotensive endotoxaemia in rats.  Br J Anaesth . 1996;  76 707-712
    PubMedGoogle Scholar
  • 94 Townsend M C, Schirmer W J, Schirmer J M, Fry D E. Low dose dopamine improves effective hepatic blood flow in murine peritonitis.  Circ Shock . 1987;  21 149-153
    PubMedGoogle Scholar
  • 95 Breslow M J, Miller C F, Parker S D. Effect of vasopressors on organ blood flow during endotoxin shock in pigs.  Am J Physiol . 1987;  252 H291-H300
    PubMedGoogle Scholar
  • 96 Bersten A D, Hersch M, Cheung H. The effect of various sympathomimetics on the regional circulations in hyperdynamic sepsis.  Surgery . 1992;  112 549-561
    PubMedGoogle Scholar
  • 97 Hasibeder W, Germann R, Wolf H J. The effects of short-term endotoxemia and dopamine on mucosal oxygenation in the porcine jejunum.  Am J Physiol . 1996;  270 G667-G675
    PubMedGoogle Scholar
  • 98 Germann R, Haisjackl M, Schwarz B. Inotropic treatment and intestinal mucosal tissue oxygenation in a model of porcine endotoxemia.  Crit Care Med . 1997;  25 1191-1197
    PubMedGoogle Scholar
  • 99 Chrusch C, Bands C, Bose D. Impaired hepatic extraction and increased splanchnic production contribute to lactic acidosis in canine sepsis.  Am J Respir Crit Care Med . 2000;  161 517-526
    PubMedGoogle Scholar
  • 100 Ruokonen E, Takala J, Uusaro A. Effect of vasoactive treatment on the relationship between mixed venous and regional oxygen saturation.  Crit Care Med . 1991;  19 1365-1369
    PubMedGoogle Scholar
  • 101 Van Lambalgen A A, Van Kraats A A, Mulder M F. High-energy phosphates in heart, liver, kidney, and skeletal muscle of endotoxemic rats.  Am J Physiol . 1994;  266 H1581-H1587
    PubMedGoogle Scholar
  • 102 Palsson J, Rickstein S E, Houltz E, Lundin S. Effects of dopamine, dopexamine and dobutamine on renal excretory function during experimental sepsis in conscious rats.  Acta Anaesthesiol Scand . 1997;  41 392-398
    PubMedGoogle Scholar
  • 103 Cain S M, Curtis S E. Systemic and regional oxygen uptake and delivery and lactate flux in endotoxic dogs infused with dopexamine.  Crit Care Med . 1991;  19 1552-1560
    PubMedGoogle Scholar
  • 104 Cain S M, Curtis S E. Systemic and regional oxygen uptake and lactate flux in endotoxic dogs resuscitated with dextran and dopexamine or dextran alone.  Circ Shock . 1992;  38 173-181
    PubMedGoogle Scholar
  • 105 Madorin W S, Martin C M, Sibbald W J. Dopexamine attenuates flow motion in ileal mucosal arterioles in normotensive sepsis.  Crit Care Med . 1999;  27 394-400
    PubMedGoogle Scholar
  • 106 Sautner T, Wessely C, Riegler M. Early effects of catecholamine therapy on mucosal integrity, intestinal blood flow, and oxygen metabolism in porcine endotoxin shock.  Ann Surg . 1998;  228 239-248
    CrossrefPubMedGoogle Scholar
  • 107 Schmidt H, Secchi A, Wellmann R. Dopexamine maintains intestinal villus blood flow during endotoxemia in rats.  Crit Care Med . 1996;  24 1233-1237
    PubMedGoogle Scholar
  • 108 Germann R, Haisjackl M, Schwarz B. Inotropic treatment and intestinal mucosal tissue oxygenation in a model of porcine endotoxemia.  Crit Care Med . 1997;  25 1191-1197
    PubMedGoogle Scholar
  • 109 Lund N, de Asla J R, Cladis F. Dopexamine hydrochloride in septic shock: effects on oxygen delivery and oxygenation of gut, liver, and muscle.  J Trauma . 1995;  38 767-775
    PubMedGoogle Scholar
  • 110 Tighe D, Moss R, Haywood G. Dopexamine hydrochloride maintains portal blood flow and attenuates hepatic ultrastructural changes in a porcine peritonitis model of multiple system organ failure.  Circ Shock . 1993;  39 199-206
    PubMedGoogle Scholar
  • 111 Van Lambalgen A A, Van Kraats A A, Mulder M F. Organ blood flow and distribution of cardiac output in dopexamine- or dobutamine-treated endotoxemic rats.  J Crit Care . 1993;  8 117-127
    CrossrefPubMedGoogle Scholar
  • 112 Webb A R, Moss R F, Tighe D. The effects of dobutamine, dopexamine and fluid on hepatic histological responses to porcine faecal peritonitis.  Intensive Care Med . 1992;  17 487-493
    PubMedGoogle Scholar
  • 113 Tighe D, Moss R, Heywood G. Goal-directed therapy with dopexamine, dobutamine, and volume expansion: effects of systemic oxygen transport on hepatic ultrastructure in porcine sepsis.  Crit Care Med . 1995;  23 1997-2007
    PubMedGoogle Scholar
  • 114 Hussain S NA, Rutledge F, Roussos C, Magder S. Effects of norepinephrine and fluid administration on the selective blood flow distribution in endotoxic shock.  J Crit Care . 1988;  1 32-42
    PubMedGoogle Scholar
  • 115 Fukuoka T, Nishimura M, Imanaka H. Effects of norepinephrine on renal function in septic patients with normal and elevated serum lactate levels.  Crit Care Med . 1989;  17 1104-1107
    PubMedGoogle Scholar
  • 116 Desjars P h, Pinaud M, Bugnon D, Tasseau F. Norepinephrine therapy has no deleterious renal effects in human septic shock.  Crit Care Med . 1989;  17 426-429
    PubMedGoogle Scholar
  • 117 Hesselvik J F, Brodin B. Low dose norepinephrine in patients with septic shock and oliguria: effects on afterload, urine flow and oxygen transport.  Crit Care Med . 1989;  17 179-180
    PubMedGoogle Scholar
  • 118 Martin C, Eon B, Saux P. Renal effects of norepinephrine used to treat septic shock patients.  Crit Care Med . 1990;  18 282-285
    PubMedGoogle Scholar
  • 119 Schmidt W, Schweppenhauser W, Secchi A. Influence of epinephrine and norepinephrine on intestinal villous blood flow during endotoxemia.  J Crit Care . 1999;  14 99-105
    CrossrefPubMedGoogle Scholar
  • 120 Zhang H, Smail N, Cabral A. Effects of norepinephrine on regional blood flow and oxygen extraction capabilities during endotoxic shock.  Am J Respir Crit Care Med . 1997;  155 1965-1971
    PubMedGoogle Scholar
  • 121 Träger K, Radermacher P, Rieger K M. Norepinephrine and nomega-monomethyl-L-arginine in porcine septic shock: effects on hepatic O2 exchange and energy balance.  Am J Respir Crit Care Med . 1999;  159 1758-1765
    PubMedGoogle Scholar
  • 122 Bersten A D, Rutten A J. Renovascular interaction of epinephrine, dopamine, and intraperitoneal sepsis.  Crit Care Med . 1995;  23 537-544
    PubMedGoogle Scholar
  • 123 Schneider A J, Groeneveld A B, Teule G J. Total body blood volume redistribution in porcine E. coli septic shock: effect of volume loading, dobutamine and norepinephrine.  Circ Shock . 1991;  35 215-222
    PubMedGoogle Scholar
  • 124 De Backer D, Zhang H, Manikis P, Vincent J L. Regional effects of dobutamine in endotoxic shock.  J Surg Res . 1996;  65 93-100
    CrossrefPubMedGoogle Scholar
  • 125 Fink M P, Kaups K L, Wang H, Rothschild H R. Maintenance of superior mesenteric arterial perfusion prevents increased intestinal mucosal permeability in endotoxic pigs.  Surgery . 1991;  110 154-161
    PubMedGoogle Scholar
  • 126 Nevière R, Chagnon J L, Vallet B. Dobutamine improves gastrointestinal mucosal blood flow in a porcine model of endotoxic shock.  Crit Care Med . 1997;  25 1371-1377
    PubMedGoogle Scholar
  • 127 Secchi A, Wellmann R, Martin E, Schmidt H. Dobutamine maintains intestinal villus blood flow during normotensive endotoxemia: an intravital microscopic study in the rat.  J Crit Care . 1997;  12 137-141
    CrossrefPubMedGoogle Scholar
  • 128 Germann R, Haisjackl M, Schwarz B. Dopamine and intestinal mucosal tissue oxygenation in a porcine model of haemorrhage.  Br J Anaesth . 1997;  79 357-362
    PubMedGoogle Scholar
  • 129 Creteur J, De Backer D, Vincent J L. A dobutamine test can disclose hepato-splanchnic hypoperfusion in septic patients.  Am J Respir Crit Care Med . 1999;  160 839-845
    PubMedGoogle Scholar
      >